Points per measurement in 2016
| Quality measurement | 0.5 point, % | 1 point, % |
| Reperfusion in STEMI/LBBB | 80 | 85 |
| Reperfusion in STEMI/LBBB within recommended time | 75 | 90 |
| Coronary angiography in NSTEMI | 75 | 80 |
| P2Y12-blockers in NSTEMI | 85 | 90 |
| ACEI/ARB in myocardial infarction, target group | 85 | 90 |
| Proportion of patients with myocardial infarction as major diagnosis (<80 years) | 90 | 95 |
| Proportion of patients with myocardial infarction as major diagnosis (<75 years) undergoing follow-up | 70 | 90 |
| Proportion of smokers who have stopped smoking 12–14 months after the myocardial infarction | 60 | 70 |
| Proportion of patients who have participated in physical training programme 12–14 months after the myocardial infarction | 50 | 60 |
| Proportion of patients who have LDL cholesterol <1,8 mmol/L or >50% reduction 12–14 months after the myocardial infarction | 40 | 60 |
| Proportion of patients with systolic blood pressure <140 mm Hg 12–14 months after the myocardial infarction | 70 | 75 |
ARB, angiotensin receptor blocker; LBBB, left bundle branch block; LDL, low density lipids; NSTEMI, non-ST elevation myocardial infarction; STEMI, ST elevation myocardial infarction.